Advancis Pharmaceutical?s revenues down $12 million

Published



Advancis Pharmaceutical Corporation, a Germantown-based pharmaceutical company focusing on developing and commercializing novel anti-infective products, reported full-year 2006 revenue totaled $4.8 million compared with full-year 2005 revenues of $16.8 million.

Product sales from the company?s Keflex and antibiotics made up all of the company?s revenue in 2006 and were $4.8 million for the year, the same as product sales from 2005.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.